Fingerprint
Dive into the research topics where Ye Ethan Li is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
Nieto, Y., Banerjee, P., Kaur, I., Basar, R., Li, Y., Daher, M., Rafei, H., Kerbauy, L. N., Kaplan, M., Marin, D., Griffin, L., Barnett, M., Bassett, R., Uprety, N., Shrestha, R., Silva, F. R., Islam, S., Ganesh, C., Borneo, Z. & Ramdial, J. & 16 others, , Jun 2025, In: Nature medicine. 31, 6, p. 1987-1993 7 p.Research output: Contribution to journal › Article › peer-review
33 Link opens in a new tab Scopus citations -
Correction to: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial (Nature Medicine, (2025), 31, 6, (1987-1993), 10.1038/s41591-025-03640-8)
Nieto, Y., Banerjee, P., Kaur, I., Basar, R., Li, Y., Daher, M., Rafei, H., Kerbauy, L. N., Kaplan, M., Marin, D., Griffin, L., Barnett, M., Bassett, R., Uprety, N., Shrestha, R., Silva, F. R., Islam, S., Ganesh, C., Borneo, Z. & Ramdial, J. & 16 others, , Aug 2025, In: Nature medicine. 31, 8, p. 2816 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Link opens in a new tab Scopus citations -
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells
Rafei, H., Basar, R., Acharya, S., Hsu, Y. S., Liu, P., Zhang, D., Bohn, T., Liang, Q., Mohanty, V., Upadhyay, R., Li, P., Phadatare, P., Dede, M., Xiong, D., Fan, H., Jones, C. M., Kunz, S., Daher, M., Nunez Cortes, A. K. & Shanley, M. & 38 others, , Jul 24 2025, In: Nature. 643, 8073, p. 1076-1086 11 p.Research output: Contribution to journal › Article › peer-review
Open Access21 Link opens in a new tab Scopus citations -
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency
Biederstädt, A., Basar, R., Park, J. M., Uprety, N., Shrestha, R., Reyes Silva, F., Dede, M., Watts, J., Acharya, S., Xiong, D., Liu, B., Daher, M., Rafei, H., Banerjee, P., Li, P., Islam, S., Fan, H., Shanley, M., Jin, J. & Kumar, B. & 16 others, , Nov 10 2025, In: Cancer cell. 43, 11, p. 2069-2088.e11Research output: Contribution to journal › Article › peer-review
Open Access14 Link opens in a new tab Scopus citations -
Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells
Melo Garcia, L., Gangadharan, A., Banerjee, P., Li, Y., Zeng, A. G. X., Rafei, H., Lin, P., Kumar, B., Acharya, S., Daher, M., Muniz-Feliciano, L., Deyter, G. M., Dominguez, G., Park, J. M., Reyes Silva, F., Nunez Cortes, A. K., Basar, R., Uprety, N., Shanley, M. & Kaplan, M. & 3 others, , Jan 28 2025, In: Cell Reports. 44, 1, 115122.Research output: Contribution to journal › Article › peer-review
Open Access7 Link opens in a new tab Scopus citations